1. The metabolism of inorganic [35S]sulphate (Na235SO4) was studied in the isolated perfused rat liver at three initial concentrations of inorganic sulphate in the perfusion medium (0, 0.65 and 1.30mM), in relation to sulphation and glucuronidation of a phenolic drug, harmol (7-hydroxy-1-methyl-9H-pyrido [3,4-b]indole). 2. [35S]Sulphate rapidly equilibrated with endogenous sulphate in the liver. It was excreted in bile and reached, at the lowest concentration in the perfusion medium, concentrations in bile that were much higher than those in the perfusion medium; at the higher sulphate concentrations, these concentrations were equal. The physiological concentration of inorganic sulphate in the liver, available for sulphation of drugs, is similar to the plasma concentration. 3. At zero initial inorganic sulphate in the perfusion medium, the rate of sulphation was very low and harmol was mainly glucuronidated. At 0.65 mM-sulphate glucuronidation was much decreased and considerable sulphation took place, indicating efficient competition of conjugation by sulphation. At 1.30mM-sulphate the sulphation increased still further. 4. The results suggest that an important factor in sulphation is the relatively high Km of synthesis ofadenosine 3'-phosphate 5'-sulphatophosphate (the co-substrate of sulphation) for inorganic sulphate, which is of the order of the plasma concentration of inorganic sulphate. The steady-state adenosine 3'-phosphate 5'-sulphatophosphate concentration may determine the rate of sulphate conjugation of drugs in the rat in vivo.
Many drugs and endogenous substances are metabolized in mammals to sulphate conjugates. These usually are rapidly excreted in urine or bile (Millburn, 1970) . The co-substrate required for sulphation, adenosine 3'-phosphate 5'-sulphatophosphate, is synthesized from ATP and inorganic sulphate in those tissues where sulphation takes place (Roy, 1971) . For xenobiotics this occurs predominantly in the liver, but the kidneys and the intestinal mucosa may contribute considerably (Roy, 1971) . In many tissues sulphate is also required for synthesis of sulphated macromolecules, such as those present in the Golgi system in the liver (Katona, 1976) , or in cartilage (Herbai, 1970) .
For these sulphation reactions the body requires a continuous supply of inorganic sulphate in order to synthesize the adenosine 3'-phosphate 5'-sulphatophosphate needed. Inorganic sulphate in blood can be provided by S-oxidation of cysteine, taken up as such or as methionine with the food; it is as yet unclear to what extent inorganic sulphate is taken up from the intestinal lumen. It has been suggested that the inorganic sulphate supply of the body can be Vol. 176 exhausted when drugs that are mainly sulphated are given in high doses. The evidence suggesting exhaustion of sulphate under these circumstances is, however, rather poor, as we have discussed elsewhere (Weitering & Mulder, 1978 ). An important factor seems to be the lack of a sensitive assay method for inorganic sulphate in plasma and tissues; thus the plasma concentration of inorganic sulphate had never been measured after a load of a substance that is mainly sulphated in vivo.
We have tried to ascertain further the role of the liver in sulphate metabolism by studying this in the isolated perfused rat liver. We were especially interested in sulphation and glucuronidation of a phenolic substrate, harmol (7-hydroxy-1-methyl-9H-pyrido [3,4-b] indole), in relation to availability and concentration of inorganic sulphate in the perfusion system; so far, no such studies are available. We have used Na235SO4 to follow the metabolism of inorganic sulphate. Our results suggest that a decreased steadystate concentration of adenosine 3'-phosphate 5'-sulphatophosphate, rather than exhaustion of inorganic sulphate as such, may be the main reason 31
for a decrease in the rate of sulphation of drugs when they are given at high doses.
Materials and Methods
Rats andperfusion procedure Male Wistar rats (body weight 295 ± 6g) were used as donors of the liver. The rats had free access to food and water. They were anaesthetized with pentobarbital sodium (60mg/kg intraperitoneally) and the liver was removed for perfusion as described by Meijer & Weitering (1970) . The liver weight was 8.7±0.6g (mean±S.E.M.). In all experiments lOOml of erythrocyte-free perfusion medium was used, containing Krebs bicarbonate buffer (Umbreit et al., 1957) from which sulphate was omitted; Na2SO4 was added to the solution as required to provide initial concentrations of 0.00, 0.65 and 1.30mM-inorganic sulphate in the perfusion medium. The perfusion medium contained also 1 % (w/v) demineralized bovine serum albumin. In these experiments with erythrocyte-free perfusion medium, sufficient oxygen was provided by an enhanced perfusion rate of 35 ml/ min. To replace the bile salts, normally re-entering from the enterohepatic circulation, in all experiments an infusion of 15mol of taurocholate/h was given, dissolved in aq. 0.9% (w/v) NaCl (0.9ml/h). The viability ofthe liver was tested by measuring perfusion flow through the liver, the pH ofthe perfusion medium and the bile flow, during the 3 h of the perfusion. Bile flow amounted in control perfusions to about 12,u1/min and decreased only slightly towards the end of the perfusion.
About 30min after initiation of the perfusion (during which period the liver equilibrated with the perfusion medium containing one of the three inorganic sulphate concentrations), Na235SO4 was added (the same amount in all perfusions: 12.5x 106c.p.m.). Exactly 10min thereafter 161umol of harmol was added to the perfusion medium, resulting in an initial concentration of 0.16mM in the perfusion medium. Samples ofthe perfusion medium were taken for analysis at various times, and bile was collected in 15min fractions before and after the addition of harmol. In control perfusions harmol was added 120min after the addition of Na235SO4; in these perfusions we could follow the behaviour ofinorganic sulphate under conditions where no exogenous substrate for sulphation was present. The perfusion lasted for 3h after the addition of harmol or, in controls, for 3h after addition of Na235SO4. Subsequently the liver was homogenized with a PotterElvehjem homogenizer in 4 vol. of aq. 0.9% (w/v) NaCl; a sample was counted by liquid-scintillation spectrometry for radioactivity, after being dissolved in scintillator containing Plasmasol (New England Nuclear Inc., Dreieichenhain, W. Germany).
Materials
Harmol, Na235SO4 and other chemicals were from the sources reported before (Mulder & Hagedoorn, 1974; Mulder & Scholtens, 1978 (Mulder & Scholtens, 1978) . Inorganic sulphate remained at the site of application of the sample, whereas harmol sulphate had RF 0.35-0.45 in this system. After separation the spots were scraped from the plate directly into scintillation vials and counted for radioactivity by liquid-scintillation spectrometry after addition of Plasmasol (Mulder & Scholtens, 1978) .
Results
Equilibration of inorganic sulphate in the perfusion medium with the endogenous sulphate pool in the isolated perfused rat liver
We perfused the isolated rat livers at three different concentrations of inorganic sulphate in the perfusion medium, 0, 0.65 and 1.30mM (initially), dissolved in Krebs bicarbonate buffer from which sulphate was omitted. Inorganic sulphate originally present in the liver was, of course, also present in the system; we show below that this amount contributes only 0.03-0.04mM to the sulphate concentration in the perfusion medium. The same amount of Na235SO4, 125000c.p.m./ml of perfusion medium, was added to the perfusion at all concentrations of sulphate in the perfusion medium. Within 8min after addition of the labelled sulphate the concentration of the radioactivity in the perfusion medium entering and leaving the liver was the same, indicating that after that time the uptake of [35S] after Na235SO4, at t = 0 (A), or 130min thereafter (e, o; see the arrow). The experiment in which harmol was added at t = 0 shows the mean of four separate experiments; the control experiment (harmol added at t = 130) is the mean of two separate perfusions.
in the perfusion medium during passage through the liver.
During the 3 h of the perfusion there was virtually no decrease of radioactivity of inorganic sulphate in the perfusion medium at the higher concentrations of sulphate, even though a substrate of sulphation, harmol, was present (see below). At the lower concentration of sulphate (zero initially) only inorganic sulphate from the liver was available, and presumably it leaked out of the liver into the perfusion medium. The results show (Fig. 1) indicates that a much greater fraction of inorganic sulphate from the perfusion medium was excreted than at the higher sulphate concentrations. This is confirmed by the finding that at 0mM-sulphate the inorganic [35S]sulphate concentration in bile was about 5-6-fold that in the perfusion medium, whereas at 1.30mM-sulphate these concentrations were equal (Fig. 2) (Mulder et al., 1975) , we found a rapid and complete disappearance of harmol from the perfusion medium within 15min after its addition. Only traces of unconjugated harmol were found in bile, less than 2 % of the dose after 3 h (Table 2 ). Most ofthe substrate was recovered as harmol sulphate and harmol glucuronide in bile ( Fig. 3 ; Table 2 ). In Fig.  3 (a) the biliary excretion of harmol glucuronide is plotted cumulatively; at the two higher concentrations of inorganic sulphate there is no statistically significant difference between the percentage of the dose converted into the glucuronide conjugate, but at the lowest sulphate concentration we found almost double the amount of harmol glucuronide. During the first 30min, 80-90% of the amount of harmol glucuronide ultimately recovered in bile after 3 h had already been excreted in bile; for the sulphate conjugate the corresponding value was 30-40% (Fig. 3b) , indicating a marked difference in excretion pattern between the two conjugates (Mulder & Scholtens, 1977) . At 0.65mM-sulphate in the perfusion medium, the sulphate conjugation of harmol increased considerably over that at 0mM-sulphate ( Fig. 3b) : it was almost twice as much. When sulphate was further increased to 1.30mM there was a further increase in the excretion of harmol sulphate, about 30 %. Table 1 . Recovery of 3S radioactivity after addition ofNa235SO4 to the isolatedperfused rat liver Harmol (16, pmol) was added to the perfusion system at three different concentrations of inorganic sulphate, IOmin after addition of Na235SO4; the perfusion was terminated 3 h after the addition of Na235SO4. The amounts of radioactivity in the perfusion medium at that time, the amounts excreted in bile and the amounts present in the liver (determined after homogenization ofthe liver) are expressed as percentages of the amount of radioactivity added to the perfusion medium. Bile and plasma radioactivity were separated in inorganic sulphate and harmol sulphate by t.l.c. All results are the means ± S.E.M. and n is the number of perfusions at each concentration of inorganic sulphate. Initially 125 000c.p.m. was added/ml of perfusion medium. 10min after the addition of Na235SO4, harmol (16/imol) was added, at t = 0. A 10ul sample of bile was subjected to t.l.c. and harmol glucuronide and harmol sulphate were separated; they were determined fluorimetrically and the total amount of each in bile is given cumulatively for the glucuronide (a) and the sulphate (b) conjugates. The means±s.E.M. (bar) are given for four (-, o) or five (A) perfusions.
Incorporation of [35S]sulphate into harmol sulphate
When harmol was added to the perfusion medium small amounts of 35S radioactivity were found in harmol sulphate in the perfusion medium (Fig. 1) , indicating incorporation of [35S]sulphate into harmol sulphate. In bile large amounts of radioactivity were found in harmol sulphate, especially in the lowVol. 176 sulphate perfusion: as much as 25 % of the radioactivity was recovered in bile as harmol sulphate (Table 1) . As expected, much less radioactivity was incorporated into harmol sulphate at the two higher sulphate concentrations (Table 1) , since there the specific radioactivity of inorganic sulphate was much lower. The specific radioactivity of inorganic sulphate was calculated from the amount of harmol sulphate (determined fluorimetrically) and the amount of radioactivity incorporated into harmol sulphate in every fraction of bile collected. We found 2070, 107 and 56c.p.m./nmol of harmol sulphate respectively at 0, 0.65 and 1.30mM-sulphate in the perfusion medium.
In control perfusions for 2h (without harmol) at both 0 and 1.30mM-sulphate virtually no radioactivity was found in bile at the harmol sulphate spot on t.l.c. When harmol was added 2h after the addition of [35S]sulphate in the control perfusion (Table 2) , clearly (35S]sulphate was incorporated into harmol sulphate; moreover, glucuronidation was the same as in the experiments in which harmol was added immediately after Na235SO4 (Table 2 ). Discussion Equilibration ofsulphate in the perfusion medium with the endogenous sulphate pool in the liver
We have previously shown that a rapid equilibration of inorganic sulphate takes place between perfusion medium or plasma and the liver (Mulder & Scholtens, 1978) . From the specific radioactivity of inorganic sulphate, as determined from harmol [35S]sulphate, the amount of sulphate originally present in the liver can be calculated, if it is assumed that both pools are completely mixed. The specific radioactivity of the total inorganic sulphate pool in the perfusion system equals (eqn. 1) the amount of radioactivity added divided by the amount of sulphate in the perfusion, i.e. the sum of the sulphate added in the perfusion medium (Y) and that present in the liver originally (C). If the reciprocal of the specific radioactivity is plotted (eqn. 2) against the amount of sulphate in the perfusion medium (Y), the intersection with the abscissa gives the amount of Sp. radioactivity =radioactivity added Sp. radioactivityx sulphate originally present in the liver (C). Fig. 4 shows this plot; the endogenous pool is about 3-4,pmol. Since the mean weight of the livers used was 8.7g, this implies an overall concentration of inorganic sulphate in the liver of about 0.4mM; if it was present only in the cytosol this would be about 0.8mM. The serum concentration of inorganic sulphate in our rats is 0.85±0.04mM (Weitering & Mulder, 1978) .
Conjugation of harmol as a function of the concentration of inorganic sulphate in the perfusion medium
The results show that glucuronidation easily compensates for the loss of sulphation at the lowest concentration of inorganic sulphate in the perfusion medium. Therefore sulphation efficiently competes with glucuronidation, especially at low doses of harmol, presumably owing to a much higher affinity of phenol sulphotransferase for harmol than that of UDP-glucuronyltransferase (Mulder et al., 1975;  in those experiments the sulphate concentration in the perfusion medium was 1.30mM). At the lowest concentration of sulphate only the 3-4umol of endogenous sulphate in the liver was present; assuming that this hepatic pool is rapidly redistributed over the perfusion medium and the liver, an overall sulphate concentration of about 0.03-0.04mM would result.
When harmol is added, about 1-2,pmol of this sulphate is used for conjugation, still leaving about 50% in the perfusion medium (Fig. 1) . At the end of the perfusion virtually no harmol sulphate was found in the perfusion medium, indicating that at these low sulphate concentrations sulphation is no longer very efficient. At 2h after its addition to the perfusion system [35S]sulphate was still available for sulphation of harmol (see Fig. 1 (Robbins, 1962; Hall & Straatsma, 1966; Levi & Wolf, 1969; Wong, 1976 (Fig. 2) , indicating that sulphate was 'passively' excreted in bile. The relatively high excretion at 0mM-sulphate may have been due either to some form of 'active transport' or to adsorption of sulphate to some component that was actively excreted in bile.
Conclusion
Inorganic sulphate in the perfusion medium (and in plasma) mixes rapidly with the endogenous sulphate pool in the liver, resulting in about equal concentrations in both compartments. Conjugation with sulphate limits glucuronidation of harmol, especially at low harmol concentration. When inorganic sulphate concentration decreases, the rate of sulphation decreases, most likely because of a relatively high Km of adenosine 3'-phosphate 5'-sulphatophosphate synthesis. Exhaustion of inorganic sulphate, though it may occur at extremely high doses of a substrate for sulphation, seems to play a less-important role.
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